Sugi Predict

Sugi Predict / Compounds / SCHEMBL141099

SCHEMBL141099

SCHEMBL141099

COC(=O)c1cc(-c2ccccc2)nc2c1[nH]c1cc(OCc3ccccc3)ccc12

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ JAK2 O60674 2/20 0.58
▸ MAOA P21397 1/20 0.48
▸ GABRA1 P14867 1/20 0.48
▸ GABRG2 P18507 1/20 0.48
▸ GABRB3 P28472 1/20 0.48
▸ GABRA3 P34903 1/20 0.48
▸ GABRA2 P47869 1/20 0.48
▸ PLA2G2A P14555 2/20 0.47
▸ CTSV O60911 1/20 0.45
▸ CTSL P07711 1/20 0.45
▸ ALDH1A1 P00352 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ KDM4E B2RXH2 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ SRD5A2 P31213 1/20 0.44
▸ HSD17B10 Q99714 1/20 0.44
▸ DHODH Q02127 5/20 0.44
▸ TACR3 P29371 3/20 0.44
▸ MDH2 P40926 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL145362 0.95 JAK2 (0.66) JAK2MAOAGABRA1GABRG2GABRB3
SCHEMBL142347 0.94 JAK2 (0.56) JAK2MAOAGABRA1GABRG2GABRB3
SCHEMBL143133 0.90 JAK2 (0.49) JAK2MAOAGABRA1GABRG2GABRB3
SCHEMBL143789 0.88 JAK2 (0.52) JAK2MAOAGABRA1GABRG2GABRB3
SCHEMBL145515 0.87 MAOA (0.49) JAK2MAOAGABRA1GABRG2GABRB3
SCHEMBL142210 0.86 JAK2 (0.63) JAK2MAOAGABRA1GABRG2GABRB3
SCHEMBL141522 0.81 JAK2 (0.80) JAK2PLA2G2AALDH1A1HPGDKDM4E
SCHEMBL140965 0.81 JAK2 (0.69) JAK2MAOAPLA2G2AALDH1A1KDM4E
SCHEMBL138351 0.81 GABRP (0.44) JAK2GABRA1GABRG2GABRB3GABRA3
SCHEMBL3705805 0.80 JAK2 (0.52) JAK2MAOAGABRA1GABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 — — US disclosed
US-8815840-B2 Carbazole and carboline kinase inhibitors BRISTOL-MYERS SQUIBB COMPANY (US) 2014-08-26 — — US disclosed
EP-2370407-B1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-06-18 — — EP disclosed
EP-2370407-B1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2014-06-18 — — EP disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 — — US disclosed
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY 2012-03-08 — — US disclosed
EP-2370407-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS Bristol-Myers Squibb Company (US) 2011-10-05 — — EP disclosed
WO-2010080474-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 — — WO disclosed
WO-2010080474-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-07-15 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120058988-A1 CARBAZOLE AND CARBOLINE KINASE INHIBITORS JAK2, JAK1, JAK3 JAK2 1/4885MAOA 2218/4885GABRA1 2062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.